Format
Sort by
Items per page

Send to

Choose Destination

Best matches for MS cannabidiol:

Search results

Items: 1 to 20 of 268

1.

Chemical characterization of leaves, male and female flowers from spontaneous cannabis (Cannabis sativa var. spontanea) growing in Hungary.

Nagy DU, Cianfaglione K, Maggi F, Sut S, Dall'Acqua S.

Chem Biodivers. 2018 Dec 13. doi: 10.1002/cbdv.201800562. [Epub ahead of print]

PMID:
30548994
2.

Cannabidiol's Upregulation of N-acyl Ethanolamines in the Central Nervous System Requires N-acyl Phosphatidyl Ethanolamine-Specific Phospholipase D.

Leishman E, Manchanda M, Thelen R, Miller S, Mackie K, Bradshaw HB.

Cannabis Cannabinoid Res. 2018 Nov 30;3(1):228-241. doi: 10.1089/can.2018.0031. eCollection 2018.

3.

Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.

Weinkle L, Domen CH, Shelton I, Sillau S, Nair K, Alvarez E.

Mult Scler Relat Disord. 2018 Nov 20;27:383-390. doi: 10.1016/j.msard.2018.11.022. [Epub ahead of print]

PMID:
30502644
4.

The unexpected identification of the cannabimimetic, 5F-ADB, and dextromethorphan in commercially available cannabidiol e-liquids.

Poklis JL, Mulder HA, Peace MR.

Forensic Sci Int. 2018 Nov 1. pii: S0379-0738(18)30704-7. doi: 10.1016/j.forsciint.2018.10.019. [Epub ahead of print]

PMID:
30442388
5.

A UHPLC-MS/MS method for the quantification of Δ9-tetrahydrocannabinol and cannabidiol in decoctions and in plasma samples for therapeutic monitoring of medical cannabis.

Barco S, Fucile C, Manfredini L, Grandis E, Gherzi M, Martelli A, Tripodi G, Mattioli F, Cangemi G.

Bioanalysis. 2018 Nov 6. doi: 10.4155/bio-2018-0184. [Epub ahead of print]

PMID:
30412688
6.

Cannabis Therapeutics and the Future of Neurology.

Russo EB.

Front Integr Neurosci. 2018 Oct 18;12:51. doi: 10.3389/fnint.2018.00051. eCollection 2018.

7.

Quantification of THC in Cannabis plants by fast-HPLC-DAD: A promising method for routine analyses.

Burnier C, Esseiva P, Roussel C.

Talanta. 2019 Jan 15;192:135-141. doi: 10.1016/j.talanta.2018.09.012. Epub 2018 Sep 6.

PMID:
30348368
8.

Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: a pilot study.

Pacifici R, Pichini S, Pellegrini M, Tittarelli R, Pantano F, Mannocchi G, Rotolo MC, Busardò FP.

Clin Chem Lab Med. 2018 Oct 17. pii: /j/cclm.ahead-of-print/cclm-2018-0566/cclm-2018-0566.xml. doi: 10.1515/cclm-2018-0566. [Epub ahead of print]

PMID:
30332386
9.

New Methods for the Comprehensive Analysis of Bioactive Compounds in Cannabis sativa L. (hemp).

Pellati F, Brighenti V, Sperlea J, Marchetti L, Bertelli D, Benvenuti S.

Molecules. 2018 Oct 14;23(10). pii: E2639. doi: 10.3390/molecules23102639.

10.

Avidekel Cannabis extracts and cannabidiol are as efficient as Copaxone in suppressing EAE in SJL/J mice.

Gallily R, Yekhtin Z.

Inflammopharmacology. 2018 Oct 5. doi: 10.1007/s10787-018-0536-3. [Epub ahead of print]

PMID:
30291491
11.

A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis.

Berman P, Futoran K, Lewitus GM, Mukha D, Benami M, Shlomi T, Meiri D.

Sci Rep. 2018 Sep 24;8(1):14280. doi: 10.1038/s41598-018-32651-4.

12.

Development and validation of a Fast gas chromatography/mass spectrometry method for the determination of cannabinoids in Cannabis sativa L.

Cardenia V, Gallina Toschi T, Scappini S, Rubino RC, Rodriguez-Estrada MT.

J Food Drug Anal. 2018 Oct;26(4):1283-1292. doi: 10.1016/j.jfda.2018.06.001. Epub 2018 Jul 3.

13.

A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis.

Arroyo González R.

Expert Rev Neurother. 2018 Oct;18(10):785-791. doi: 10.1080/14737175.2018.1510772. Epub 2018 Sep 20.

PMID:
30235965
14.

Cannabinoid concentrations in blood and urine after smoking cannabidiol joints.

Meier U, Dussy F, Scheurer E, Mercer-Chalmers-Bender K, Hangartner S.

Forensic Sci Int. 2018 Oct;291:62-67. doi: 10.1016/j.forsciint.2018.08.009. Epub 2018 Aug 11.

PMID:
30149280
15.

Simultaneous quantification of THC-COOH, OH-THC, and further cannabinoids in human hair by gas chromatography-tandem mass spectrometry with electron ionization applying automated sample preparation.

Kieliba T, Lerch O, Andresen-Streichert H, Rothschild MA, Beike J.

Drug Test Anal. 2018 Aug 24. doi: 10.1002/dta.2490. [Epub ahead of print]

PMID:
30144294
16.

Variability of Multiple Sclerosis Spasticity Symptoms in Response to THC:CBD Oromucosal Spray: Tracking Cases through Clinical Scales and Video Recordings.

Flachenecker P, Saccà F, Vila C.

Case Rep Neurol. 2018 Jul 12;10(2):169-176. doi: 10.1159/000490376. eCollection 2018 May-Aug.

17.

Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.

Elliott DM, Singh N, Nagarkatti M, Nagarkatti PS.

Front Immunol. 2018 Aug 3;9:1782. doi: 10.3389/fimmu.2018.01782. eCollection 2018.

18.

Simultaneous quantification of cannabinoids tetrahydrocannabinol, cannabidiol and CB1 receptor antagonist in rat plasma: An application to characterize pharmacokinetics after passive cannabis smoke inhalation and co-administration of rimonabant.

Ravula A, Chandasana H, Setlow B, Febo M, Bruijnzeel AW, Derendorf H.

J Pharm Biomed Anal. 2018 Oct 25;160:119-125. doi: 10.1016/j.jpba.2018.07.004. Epub 2018 Jul 19.

PMID:
30077950
19.

Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship.

Contin M, Mancinelli L, Perrone A, Sabattini L, Mohamed S, Scandellari C, Foschi M, Vacchiano V, Lugaresi A, Riva R.

Clin Neuropharmacol. 2018 Sep/Oct;41(5):171-176. doi: 10.1097/WNF.0000000000000294.

PMID:
30024443
20.

Commercial cannabis consumer products part 1: GC-MS qualitative analysis of cannabis cannabinoids.

Ciolino LA, Ranieri TL, Taylor AM.

Forensic Sci Int. 2018 Aug;289:429-437. doi: 10.1016/j.forsciint.2018.05.032. Epub 2018 Jun 6.

PMID:
29954632

Supplemental Content

Loading ...
Support Center